Neuro-Oncological Ventral Antigen 2 (NOVA2) Peptide
NOVA2
Reactivity: Mammalian
Host: Synthetic
WB, BP, IHC
Catalog No. ABIN938017
Quick Overview for Neuro-Oncological Ventral Antigen 2 (NOVA2) Peptide (ABIN938017)
Target
NOVA2
(Neuro-Oncological Ventral Antigen 2 (NOVA2))
Origin
Mammalian
Source
Synthetic
Application
Western Blotting (WB), Blocking Peptide (BP), Immunohistochemistry (IHC)
-
-
Peptide Type
- Synthetic
-
Sequence
- EPEQVHKAVS AIVQKVQEDP QSSSCLNISY ANVAGPVANS NPTGSPYASP
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of NOVA2 antibody,
Alternative Names: NOVA2 control peptide, NOVA2 antibody Blocking Peptide, Anti-NOVA2 Blocking Peptide, Neuro-Oncological Ventral Antigen 2 Blocking Peptide, NOVA2, NOVA-2, NOVA 2, NOVA-2 Blocking Peptide, NOVA 2 Blocking Peptide -
Purification
- The antibody is affinity-purified from rabbit antiserum by affinity chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide is removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- NOVA2 (Neuro-Oncological Ventral Antigen 2 (NOVA2))
-
Background
- NOVA2 may regulate RNA splicing or metabolism in a specific subset of developing neurons. It binds single strand RNA.
-
Molecular Weight
- 54 kDa
Target
-
You are here:
